Skip to main content
. 2018 Jan 16;15(3):3766–3771. doi: 10.3892/ol.2018.7810

Table IV.

Number of patients with low and high XPA expression in the NAC effective and NAC ineffective groups.

Number of patients (%)

XPA expression NAC + OP + R n=31 NAC + R n=25 P-value
Low expression (≤3 score) 15 (88%) 2 (12%) 0.001a
High expression (≥4 score) 16 (41%) 23 (59%)
a

χ2 test; NAC+OP+R, neoadjuvant chemotherapy + surgery + radiotherapy; NAC+R, neoadjuvant chemotherapy + radiotherapy; XPA, xeroderma pigmentosum complementation group A.